<Document id="0000378" source="ADAM" url="https://www.nlm.nih.gov/medlineplus/ency/article/003518.htm">
 
<Focus>B-cell leukemia/lymphoma panel</Focus>
<FocusAnnotations>
	<Category>Disease</Category>
	<UMLS>
		<CUIs>
			<CUI>C0023418</CUI>
		</CUIs>
		<SemanticTypes>
			<SemanticType>T191</SemanticType>
		</SemanticTypes>
		<SemanticGroup>Disorders</SemanticGroup>
	</UMLS>
	<Synonyms>
		<Synonym>B lymphocyte cell surface markers</Synonym>
	</Synonyms>
</FocusAnnotations>
<QAPairs>
	<QAPair pid="1">
			<Question qid="0000378-1" qtype="information">What is (are) B-cell leukemia/lymphoma panel ?</Question>
			<Answer>B-cell leukemia/lymphoma panel is a blood test that looks for certain proteins on the surface of white blood cells called B-lymphocytes. The proteins are markers that may help diagnose  leukemia  or lymphoma.</Answer>
	</QAPair>
	<QAPair pid="7">
			<Question qid="0000378-7" qtype="susceptibility">Who is at risk for B-cell leukemia/lymphoma panel? ?</Question>
			<Answer>No information found.</Answer>
	</QAPair>
</QAPairs>
</Document>